Pathologic complete response and survival outcomes after carboplatin-based neoadjuvant chemotherapy in triple-negative breast cancer: a real-world cohort
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with a high risk of early relapse. The addition of carboplatin to neoadjuvant chemotherapy increases pathologic complete response (pCR) rates, which are strongly associated with survival outcomes. In the Brazilian pu...